In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in
general, with a particular focus on adenoviruses. These serve as a model to elucidate how …

Abstract Purpose of Review Cryopreservation and its associated freezing and thawing
procedures–short “freeze-thawing”–are among the final steps in economically viable …

Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries
continues to rise with 48,512 HCT in 43,581 patients, comprising of 19,798 (41%) allogeneic …

The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …

A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469
patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers …

Hematopoietic stem cell transplantation (HSCT) is an established procedure for many
acquired and congenital disorders of the hematopoietic system. A record number of 42 171 …

Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital
disorders of the hematopoietic system. Number of transplants performed in Europe and …

Data on 68 146 hematopoietic stem cell transplants (HSCTs)(53% autologous and 47%
allogeneic) gathered by 1566 teams from 77 countries and reported through their regional …

Background The transplantation of cells, tissues, and organs has been recognised by WHO
as an important medical task for its member states; however, information about how to best …

Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …